In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recently emanating human infectious coronavirus that causes COVID-19 disease. On 11th March 2020, it has been announced as a pandemic by the World Health Organization (WHO). Recently, several repositioned drugs have been subjected to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Mahmoud A. A., Abdelrahman, Alaa H. M., Allemailem, Khaled S., Almatroudi, Ahmad, Moustafa, Mahmoud F., Hegazy, Mohamed-Elamir F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776322/
https://www.ncbi.nlm.nih.gov/pubmed/33387249
http://dx.doi.org/10.1007/s10930-020-09945-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776322/
https://www.ncbi.nlm.nih.gov/pubmed/33387249
http://dx.doi.org/10.1007/s10930-020-09945-6

Ejemplares similares